These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34557423)

  • 21. Susceptibility of spiny rats (Proechimys semispinosus) to Leishmania (Viannia) panamensis and Leishmania (Leishmania) chagasi.
    Travi BL; Arteaga LT; Leon AP; Adler GH
    Mem Inst Oswaldo Cruz; 2002 Sep; 97(6):887-92. PubMed ID: 12386716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia.
    Franco-Muñoz C; Manjarrés-Estremor M; Ovalle-Bracho C
    PLoS One; 2018; 13(4):e0196247. PubMed ID: 29698432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia).
    Gómez MA; Navas A; Prieto MD; Giraldo-Parra L; Cossio A; Alexander N; Gore Saravia N
    Clin Infect Dis; 2021 May; 72(10):e484-e492. PubMed ID: 32818964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic capability of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis in golden hamsters.
    Martinez JE; Travi BL; Valencia AZ; Saravia NG
    J Parasitol; 1991 Oct; 77(5):762-8. PubMed ID: 1919926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of
    Regli IB; Fernández OL; Martínez-Salazar B; Gómez MA; Saravia NG; Tacchini-Cottier F
    Front Immunol; 2018; 9():3040. PubMed ID: 30622537
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune Profile of the Nasal Mucosa in Patients with Cutaneous Leishmaniasis.
    Gómez-Zafra MJ; Navas A; Jojoa J; Murillo J; González C; Gómez MA
    Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32094254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular identification of the parasites causing cutaneous leishmaniasis on the Caribbean coast of Colombia.
    Martínez LP; Rebollo JA; Luna AL; Cochero S; Bejarano EE
    Parasitol Res; 2010 Feb; 106(3):647-52. PubMed ID: 20084397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of Leishmania (Viannia) panamensis and Leishmania (V.) guyanensis using BccI for hsp70 PCR-RFLP.
    Montalvo Alvarez AM; Nodarse JF; Goodridge IM; Fidalgo LM; Marin M; Van Der Auwera G; Dujardin JC; Bernal ID; Muskus C
    Trans R Soc Trop Med Hyg; 2010 May; 104(5):364-7. PubMed ID: 20227738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antileishmanial activity of synthetic analogs of the naturally occurring quinolone alkaloid N-methyl-8-methoxyflindersin.
    Torres Suarez E; Granados-Falla DS; Robledo SM; Murillo J; Upegui Y; Delgado G
    PLoS One; 2020; 15(12):e0243392. PubMed ID: 33370295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential inflammatory responses associated with Leishmania major and L tropica in culture.
    Darzi F; Davoudian R; Nateghi Rostami M
    Parasite Immunol; 2021 Aug; 43(8):e12841. PubMed ID: 33914948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ecological interactions of sand flies, hosts, and Leishmania panamensis in an endemic area of cutaneous leishmaniasis in Colombia.
    Posada-López L; Velez-Mira A; Cantillo O; Castillo-Castañeda A; Ramírez JD; Galati EAB; Galvis-Ovallos F
    PLoS Negl Trop Dis; 2023 May; 17(5):e0011316. PubMed ID: 37167348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulence factor RNA transcript expression in the
    Kariyawasam R; Mukkala AN; Lau R; Valencia BM; Llanos-Cuentas A; Boggild AK
    Trop Med Health; 2019; 47():25. PubMed ID: 31007536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival.
    Gómez MA; Navas A; Márquez R; Rojas LJ; Vargas DA; Blanco VM; Koren R; Zilberstein D; Saravia NG
    J Antimicrob Chemother; 2014 Jan; 69(1):139-49. PubMed ID: 23975742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression patterns associated with Leishmania panamensis infection in macrophages from BALB/c and C57BL/6 mice.
    Restrepo CM; Llanes A; Herrera L; Ellis E; Lleonart R; Fernández PL
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009225. PubMed ID: 33617537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.
    Guerra JA; Prestes SR; Silveira H; Coelho LI; Gama P; Moura A; Amato V; Barbosa Md; Ferreira LC
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e980. PubMed ID: 21408116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous transcriptional profiling of Leishmania major and its murine macrophage host cell reveals insights into host-pathogen interactions.
    Dillon LA; Suresh R; Okrah K; Corrada Bravo H; Mosser DM; El-Sayed NM
    BMC Genomics; 2015 Dec; 16():1108. PubMed ID: 26715493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.
    Galdino H; Maldaner AE; Pessoni LL; Soriani FM; Pereira LI; Pinto SA; Duarte FB; Gomes CM; Fleuri AK; Dorta ML; de Oliveira MA; Teixeira MM; Batista AC; Joosten LA; Vieira LQ; Ribeiro-Dias F
    BMC Infect Dis; 2014 May; 14():249. PubMed ID: 24884781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Mouse Model of Ulcerative Cutaneous Leishmaniasis by
    Muñoz-Durango N; Gómez A; García-Valencia N; Roldán M; Ochoa M; Bautista-Erazo DE; Ramírez-Pineda JR
    Front Microbiol; 2022; 13():907631. PubMed ID: 35770175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic and Functional Profiles of Antigen-Specific CD4
    Egui A; Ledesma D; Pérez-Antón E; Montoya A; Gómez I; Robledo SM; Infante JJ; Vélez ID; López MC; Thomas MC
    Front Cell Infect Microbiol; 2018; 8():393. PubMed ID: 30510917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.